This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The risk factors for postoperative embolism included Black race, interstitial fibrosis, advanced-stage disease requiring bilobectomy or pneumonectomy, and increased operative duration. occurrence of postoperative PE in patients undergoing a first-time pulmonary resection for lung cancer. occurrence of postoperative VTE and a 1.3%
BackgroundPercutaneous mechanical thrombectomy (PMT) is increasingly used in the treatment of intermediate and high-risk acute pulmonaryembolism (PE), and the treatment of high-risk PE with the aid of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has also been reported. The mortality rate was 27.3%
tim.hodson Wed, 09/04/2024 - 15:34 Aug. 29, 2024 – Jupiter Endovascular, Inc., SPIRARE II is a prospective, single-arm, multicenter pivotal trial that will enroll up to 145 patients with acute, intermediate-risk PE treated with the Vertex Pulmonary Embolectomy System at up to 25 U.S. recently announced that the U.S.
milla1cf Tue, 03/26/2024 - 11:12 March 26, 2024 — Medical imaging AI company Avicenna.AI announced that it has received 510(k) clearance from the US Food and Drug Administration for its CINA-iPE and CINA-ASPECTS products. CINA-iPE and CINA-ASPECTS are the latest tools from Avicenna.AI
A new Intelligent thrombo-suction catheter system , is being introduced for treatment of acute pulmonary embolism.This device regulates the force with which thrombus is sucked , with less injury and bleeding and better outcomes. Human studies & Evidence The experience from this device was presented in ESC 2024 London.
Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonaryembolism (PE).
BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonaryembolism (PE).METHODS:This Patients were divided into early (<12 hours) and delayed CBT (12 hours) groups.
In patients with narrow QRS ( not this patient), this pattern is highly suggestive of acute pulmonaryembolism. Although it was technically difficult and the quality therefore leaves a lot to be desired, you can still make out RV dilation and septal flattening which is much more suggestive of pulmonaryembolism than OMI.
Publication date: Available online 28 October 2024 Source: The American Journal of Cardiology Author(s): Aryan Mehta, Mridul Bansal, Siddhant Passey, Saurabh Joshi, Carlos L Alviar, Jason N Katz, J Dawn Abbott, Saraschandra Vallabhajosyula
Publication date: 15 January 2024 Source: The American Journal of Cardiology, Volume 211 Author(s): Esra Dönmez, Sevgi Özcan, İrfan Sahin, Murat Ziyrek, Ertugrul Okuyan
milla1cf Fri, 05/31/2024 - 07:00 May 31, 2024 — In the United States there are over 8 million active athletes. Clinical Cases and Poster Presentations The following list provides a brief look at the clinical cases and posters to be presented during the ACC Care of the Athletic Heart 2024 conference.
Publication date: Available online 31 October 2024 Source: The American Journal of Cardiology Author(s): Marouane Boukhris, Thomas Madelrieux, Guillaume Signoret, Cyrille Boulogne, Paul Gendrin, Aymeric Rouchaud, Victor Aboyans
Publication date: Available online 31 December 2024 Source: The American Journal of Cardiology Author(s): Aryan Mehta, Mridul Bansal, Abhishek Singh, Ritika Kompella, Anindita Chanda, Chirag Mehta, Christopher J Mullin, J Dawn Abbott, Saraschandra Vallabhajosyula
Publication date: Available online 4 November 2024 Source: The American Journal of Cardiology Author(s): Eugene Yuriditsky, Robert S. Zhang, Peter Zhang, Radu Postelnicu, Allison A. Greco, James. M Horowitz, Samuel Bernard, Orly Leiva, Vikramjit Mukherjee, Kerry Hena, Lindsay Elbaum, Carlos L. Alviar, Norma M. Keller, Sripal Bangalore
Publication date: Available online 6 April 2024 Source: The American Journal of Cardiology Author(s): Natalie Hickerson, Ramzi Ibrahim, Enkhtsogt Sainbayar, Hoang Nhat Pham, Sabrina Soin, Mohammed Salih, João Paulo Ferreira, See-Wei Low, Mamas A.
CT of the chest showed no pulmonaryembolism but bibasilar infiltrates. For more on Torsades de Pointes vs PMVT See My Comment in the October 18, 2023 post and the September 2, 2024 post in Dr. Smith's ECG Blog ). She was intubated. Bedside cardiac ultrasound showed moderately decreased LV function. J Am Coll Cardiol.
Publication date: Available online 11 June 2024 Source: The American Journal of Cardiology Author(s): Anas Noman, Brian Stegman, Aaron R DuCoffe, Ambarish Bhat, Kyle Hoban, Matthew C Bunte
Circulation, Volume 150, Issue Suppl_1 , Page A4145271-A4145271, November 12, 2024. Given ongoing embolic phenomena, likely from LSE, she underwent MVR with mechanical valve and LA appendage ligation and continued mycophenolate and warfarin. Acute stroke workup was negative, and syncope was attributed to possible brief seizure.
Findings from the PEERLESS study presented at TCT 2024 showed that patients at intermediate risk of pulmonaryembolism (PE) who were treated with large-bore mechanical thrombectomy (LBMT) had significantly lower risk of all-cause mortality.
Smith comment: before reading anything else, this case screamed pulmonaryembolism to me. I would do bedside ultrasound to look at the RV, look for B lines as a cause of hypoxia (which would support OMI, and argue against PE), and if any doubt persists, a rapid CT pulmonary angiogram.
Publication date: Available online 11 January 2024 Source: The American Journal of Cardiology Author(s): Marco Zuin, Gregory Piazza, Gianluca Rigatelli, Claudio Bilato, Amedeo Bongarzoni, Stanislav Henkin, Pietro Zonzin, Franco Casazza, Loris Roncon
In other words: 1) infarct of the LAD territory (much of which could be old) and 2) inferior-posterior-lateral infarct. == MY Comment , by K EN G RAUER, MD ( 9/27 /2024 ): == I found today's case insightful for a number of reasons. See Discussion in the June 29, 2024 post of Dr. Smith' ECG Blog ). But because Dr.
Circulation, Volume 150, Issue Suppl_1 , Page A4131838-A4131838, November 12, 2024. CT Abdomen and Pelvis showed an enhancing heterogenous lesion at the left superior renal pole, left adrenal gland lesion, and a pulmonary artery filling defect. A 66-year-old male presented with 5 months of worsening left flank and lower back pain.
Stroke, Volume 55, Issue Suppl_1 , Page A134-A134, February 1, 2024. There were 20 (1%) pulmonaryembolisms and 35 (1.8%) acute deep venous thromboses, but no other stroke/thrombotic complications in NIS.Conclusions:We found very few thrombotic events shortly after OHSS diagnosis using two large datasets.
He was started on a heparin drip and CTA of the chest was ordered to rule out pulmonaryembolism. This is a case like many others posted (see list below) and the EKG from the patient’s original presentation can be quickly recognized as diagnostic for pulmonaryembolism. Accessed May 28, 2024. In fact, Kosuge et al.
Circulation, Volume 150, Issue Suppl_1 , Page A4140751-A4140751, November 12, 2024. this clinical case, we discussed sub-massive pulmonaryembolism (PE) complicated by a right heart clot-in-transit presenting insidiously. On arrival, his troponins were elevated 373, elevated BNP 934.
Circulation, Volume 150, Issue Suppl_1 , Page A4139677-A4139677, November 12, 2024. She had idiopathic ventricular fibrillation in 1992, treated with an EPD (Picture 1A), later replaced by a transvenous ICD.She was diagnosed with left femoral deep venous thrombosis and bilateral pulmonaryembolism and started on therapeutic anticoagulation.
Stroke, Volume 55, Issue Suppl_1 , Page AWP153-AWP153, February 1, 2024. days, P<0.001) and ICU complications such as pulmonaryembolism (PE) and pneumonia (10 vs 4 days; p <0.001) significantly increased the ICU LoS. Patients with mRS 0-2 at discharge (33%) had shorter ICU LoS (2.8 P<0.001).
Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonaryembolism (PE) treatment. Its SCAI Scientific Sessions 2024 were held May 2-4 in Long Beach, CA.
Eur Heart J Dig Health 2023 == MY Comment , by K EN G RAUER, MD ( 1/17/ 2024 ): == Today’s post by Dr. McLaren once again emphasizes the importance of “ proportionality ” — for assessing the clinical significance of ST-T wave appearance in a patient who presents with CP ( C hest P ain ). But ECG #1 is not "normal".
Circulation, Volume 150, Issue Suppl_1 , Page A4140255-A4140255, November 12, 2024. Pulmonaryembolism (PE) is the third leading cause of cardiovascular death. We conducted a prospective observational study examining 188 PE patients attending a dedicated PulmonaryEmbolism Response Team (PERT) Clinic.
tim.hodson Thu, 11/07/2024 - 09:42 Nov. 5, 2024 —Penumbra, Inc. The late-breaking study was presented this week at the Vascular Interventional Advances (VIVA) 2024 Conference. This data was presented separately in a symposium during the VIVA 2024 Conference. Patel, M.D.,
His initial high sensitivity troponin I returned at 1300 ng/L and given that his cardiac workup was otherwise unremarkable, a CT was obtained to evaluate for pulmonaryembolism and aortic aneurysm or dissection but this too was unrevealing. Also: electrical instability, pulmonary edema, or hypotension.
By itself seeing this ECG pattern does not necessarily mean that the patient has a pulmonaryembolism. Today's discussion by Dr. Smith is highly insightful in showing how dramatically the timing of the ECG ( or hopefully ECGs ) that we obtain may be with respect to the ECG picture that we receive.
Smith : This is classic for pulmonaryembolism (PE). Acute pulmonaryembolism was confirmed on CT angiogram: The patient did well. Cardiac Ultrasound may be a surprisingly easy way to help make the diagnosis Answer: pulmonaryembolism. Vitals were within normal limits. Now another, with ultrasound.
No pulmonaryembolism is identified. 2022;Available from: [link] Click here to sign up for Queen of Hearts Access. == MY Comment, by K EN G RAUER, MD ( 10/27/2024 ): == I view today's case as unfortunate. While in the ED, patient's pain worsened to previous severity of 6/10 pain and improved to 3/10 on NTG drip.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content